News Medical on MSN5d
Stem cell-derived heart patches show promise for heart failure treatment
Innovative muscle patches derived from stem cells demonstrate efficacy in heart repair, improving function in primates and a ...
News Medical on MSN6d
New treatment identified for peripheral nerve sheath tumors
A multicenter collaboration led by the Bellvitge Biomedical Research Institute (IDIBELL) - Institut Català d'Oncologia (ICO) ...
Silexion Therapeutics Reports Strong Tumor Growth Reduction from Systemic Administration of SIL-204 in Preclinical Pancreatic Cancer Models
New preclinical findings provide validation for Silexion’s new systemic administration approach for SIL-204, demonstrating ...
Triple combination of inhibitors emerges as potential new treatment for aggressive cancer
A multicenter collaboration has identified a potential new treatment for an aggressive sarcoma arising in the nerves. The ...
Why Is Silexion Therapeutics Stock Soaring Over 100% On Tuesday?
Silexion Therapeutics Corp. (NASDAQ:SLXN) released new preclinical data for SIL-204, its next-generation siRNA therapeutic ...
Too Old to Operate8d
DBF4 Overexpression as a Prognostic Marker in ccRCC
The following is a summary of “Clinical significance and pro-oncogenic function of DBF4 in clear cell renal cell carcinoma,” published in the January 2025 issue of Urology by Chen et al. Clear cell ...
Hosted on MSN20d
Bridging the gap: Models that mirror human tumors in the lab
Using single-cell RNA sequencing, they have analyzed tumor tissues at an unprecedented ... in neuroblastoma and create patient-derived xenograft (PDX) organoids. "These advancements will not ...
Dewpoint Therapeutics Announces DPTX3496 as a Development Candidate for the Treatment of Colorectal, Breast, and Lung Cancers
Dewpoint Therapeutics’ second development candidate, DPTX3496 is an oral, small molecule acting via a novel ...
Pharmaceutical Technology7y
Pharmatest Launches Novel Humanised Mouse Model of Tumor Growth in Bone
Pharmatest Services has announced it has collaborated with Taconic Biosciences to develop a novel humanised mouse model of tumour ...
Silexion Therapeutics reports preclinical data for SIL-204
Silexion Therapeutics (SLXN) announced new preclinical data for SIL-204, its next-generation siRNA therapeutic candidate. The findings ...